Milne A C, Potter J, Avenell A
Health Services Research Unit (Foresterhill Lea), University of Aberdeen, Foresterhill, Aberdeen, Aberdeenshire, Scotland, UK, AB25 2ZD.
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003288. doi: 10.1002/14651858.CD003288.pub2.
Evidence for the effectiveness of nutritional supplements containing protein and energy, which are often prescribed for older people, is limited. Furthermore malnutrition is more common in this age group and deterioration of nutritional status can occur during illness. It is important to establish whether supplementing the diet is an effective way of improving outcomes for older people at risk from malnutrition.
This review examined the evidence from trials for improvement in nutritional status and clinical outcomes when extra protein and energy were provided, usually in the form of commercial 'sip-feeds'.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Healthstar, CINAHL, BIOSIS, CAB abstracts. We also hand searched nutrition journals and reference lists and contacted 'sip-feed' manufacturers. Date of most recent search: March 2004.
Randomised controlled trials and quasi-randomised controlled trials of oral protein and energy supplementation in older people with the exception of groups recovering from cancer treatment or in critical care.
Two reviewers independently assessed trials prior to inclusion and independently extracted data and assessed trial quality. Authors of trials were contacted for further information as necessary.
Forty-nine trials with 4790 randomised participants have been included in the review. Most included trials had poor study quality. The pooled weighted mean difference [WMD] for percentage weight change showed a benefit of supplementation of 2.3% (95% confidence interval (CI) 1.9 to 2.7) from 34 trials. There was a reduced mortality in the supplemented compared with control groups (relative risk (RR) 0.74, CI 0.59 to 0.92) from 32 trials. The risk of complications from 14 trials showed no significant difference (RR 0.95, 95% CI 0.81 to 1.11). Few trials were able to suggest any functional benefit from supplementation. The pooled weighted mean difference (WMD) for length of stay from 10 trials also showed no statistically significant effect (WMD -1.98 days, 95% CI -5.20 to 1.24).
AUTHORS' CONCLUSIONS: Supplementation produces a small but consistent weight gain in older people. There may also be a beneficial effect on mortality. However, there was no evidence of improvement in clinical outcome, functional benefit or reduction in length of hospital stay with supplements. Additional data from large-scale multi-centre trials are still required.
常用于老年人的含蛋白质和能量的营养补充剂有效性证据有限。此外,营养不良在该年龄组更为常见,且患病期间营养状况可能恶化。确定补充饮食是否是改善有营养不良风险的老年人预后的有效方法很重要。
本综述考察了通常以商业“流食”形式提供额外蛋白质和能量时,改善营养状况和临床预后的试验证据。
我们检索了Cochrane对照试验中心注册库(CENTRAL)、MEDLINE、EMBASE、Healthstar、CINAHL、BIOSIS、CAB文摘库。我们还手工检索了营养学期刊和参考文献列表,并联系了“流食”制造商。最近一次检索日期:2004年3月。
除了从癌症治疗中恢复的人群或重症监护人群外,针对老年人口服蛋白质和能量补充剂的随机对照试验和半随机对照试验。
两名综述作者在纳入试验前独立评估试验,并独立提取数据和评估试验质量。必要时联系试验作者获取更多信息。
本综述纳入了49项试验,4790名随机参与者。大多数纳入试验的研究质量较差。来自34项试验的体重变化百分比的合并加权平均差(WMD)显示补充剂有2.3%的益处(95%置信区间(CI)1.9至2.7)。来自32项试验的补充组与对照组相比死亡率降低(相对风险(RR)0.74,CI 0.59至0.92)。14项试验的并发症风险无显著差异(RR 0.95,95%CI 0.81至1.11)。很少有试验能够表明补充剂有任何功能益处。来自10项试验的住院时间的合并加权平均差(WMD)也未显示出统计学显著效果(WMD -1.98天,95%CI -5.20至1.24)。
补充剂使老年人体重有小幅但持续的增加。对死亡率可能也有有益影响。然而,没有证据表明补充剂能改善临床预后、带来功能益处或缩短住院时间。仍需要大规模多中心试验的更多数据。